Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...
The International Vaccine Institute (IVI) and South Korean company EuBiologics exchanged an MOU to cooperate in the clin...
Korean researchers at the Center for Cognition and Sociality, within the Institute for Basic Science (IBS...
Marine Bio Co Ltd, a South Korean firm with the support of the Korean Trade-Investment Promotion Agency (KOTRA)&nbs...
The government of the Republic of Korea (ROK) has decided to contribute $3 million in 2020 for the first time to the Coa...
Amorepacific R&D Center, together with the Korea Advanced Institute of Science & Technology (KAIST), developed a...
The International Vaccine Institute (IVI) and Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memo...
OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced...
The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to j...
The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans...
Samsung Biologics has officially begun construction of its Plant 4 in Incheon, South Korea. Dubbed the "Super Plant...
South Korea based Samsung Biologics' partnership with Eli Lilly and Company is expected to greatly accelerate the global...
South Korea based Medit has recently announced an update to its Medit Link software with the release of patient com...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...
KT Corporation, South Korea's largest telecommunications company, is diversifying its business from robotics t...
Korea's Celltrion Group on 5 Nov 2020 announced results from the ongoing Phase I clinical trial of CT-P59, an anti-COVID...
Agilent Technologies Inc. has announced the signing of a memorandum of understanding (MOU) with GI Innovation ...
US based Humanigen, Inc., a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-...
